CLINICAL RESEARCH: VALVULAR HEART DISEASE
Does lowering pulmonary arterial pressure eliminate severe functional tricuspid regurgitation?
Insights from pulmonary thromboendarterectomy
H. Mehrdad Sadeghi, MD*,*,
Bruce J. Kimura, MD, FACC ,
Ajit Raisinghani, MD, FACC*,
Daniel G. Blanchard, MD, FACC*,
Ehtisham Mahmud, MD, FACC*,
Peter F. Fedullo, MD ,
Stuart W. Jamieson, MB and
Anthony N. DeMaria, MD, MACC*
* Cardiology, University of California-San Diego Medical Center, San Diego, California, USA
Pulmonary Medicine, University of California-San Diego Medical Center, San Diego, California, USA
Cardiothoracic Surgery, University of California-San Diego Medical Center, San Diego, California, USA
Division of Cardiology, Scripps-Mercy Hospital, San Diego, California, USA
Manuscript received March 5, 2003;
revised manuscript received November 19, 2003,
accepted December 19, 2003.
* Reprint requests and correspondence: Dr. H. Mehrdad Sadeghi, 765 Medical Center Court, Suite 211, Chula Vista, California 91911, USA.
hmsmd1{at}hotmail.com
Presented in part at the 11th Annual Scientific Sessions of the American Society of Echocardiography, Chicago, Illinois, June 2000.
OBJECTIVES: Because pulmonary thromboendarterectomy (PTE) can result in an immediate reduction in pulmonary artery (PA) pressure, we sought to evaluate the effect of PTE on severe tricuspid regurgitation (TR) without tricuspid annuloplasty.
BACKGROUND: Few data exist regarding the frequency and magnitude of functional TR improvement after reduction in PA pressure.
METHODS: We identified 27 patients with severe TR, defined by a regurgitant index (RI) >33%, who underwent PTE. The RI, tricuspid annular diameter (TAD), apical displacement of leaflet coaptation, and estimated PA systolic pressure were determined on pre- and post-PTE echocardiograms. Patients were stratified based on resolution (RI  33%) or persistence (RI >33%) of severe TR.
RESULTS: Comparing pre- and post-PTE echocardiography results, severe TR resolved in 19 of 27 (70%) patients. This group had a more effective PA systolic pressure reduction after PTE (49 ± 20 mm Hg vs. 32 ± 16 mm Hg by echocardiography, p = 0.075, and 37 ± 16 mm Hg vs. 16 ± 13 mm Hg by catheter measurement, p = 0.004). No difference was observed in TAD, apical displacement of the tricuspid valve, or other features compared with the group with persistent severe TR. There was a trend toward longer hospital stays in the group with persistent severe TR (19 ± 15 days vs. 14 ± 9 days; p = 0.55).
CONCLUSIONS: After significant PA pressure reduction by PTE, severe functional TR with a dilated annulus may improve without annuloplasty despite dilated tricuspid annulus diameters.
|
Abbreviations and Acronyms
| | AF | = atrial fibrillation | | CTEPH | = chronic thromboembolic pulmonary hypertension | | JA | = jet area | | PA | = pulmonary artery | | PTE | = pulmonary thromboendarterectomy | | PVR | = pulmonary vascular resistance | | RA | = right atrial | | RI | = regurgitant index | | RV | = right ventricle/ventricular | | TAD | = tricuspid annular diameter | | TR | = tricuspid regurgitation |
|
This article has been cited by other articles:
|
|
|
|
 
C. J. Bruce and H. M. Connolly
Right-Sided Valve Disease Deserves a Little More Respect
Circulation,
May 26, 2009;
119(20):
2726 - 2734.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Shiran and A. Sagie
Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management.
J. Am. Coll. Cardiol.,
February 3, 2009;
53(5):
401 - 408.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Mutlak, D. Aronson, J. Lessick, S. A. Reisner, S. Dabbah, and Y. Agmon
Functional Tricuspid Regurgitation in Patients With Pulmonary Hypertension: Is Pulmonary Artery Pressure the Only Determinant of Regurgitation Severity?
Chest,
January 1, 2009;
135(1):
115 - 121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Ogino, M. Ando, H. Matsuda, K. Minatoya, H. Sasaki, N. Nakanishi, S. Kyotani, H. Imanaka, and S. Kitamura
Japanese Single-Center Experience of Surgery for Chronic Thromboembolic Pulmonary Hypertension
Ann. Thorac. Surg.,
August 1, 2006;
82(2):
630 - 636.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Fukuda, A. M. Gillinov, P. M. McCarthy, W. J. Stewart, J.-M. Song, T. Kihara, M. Daimon, M.-S. Shin, J. D. Thomas, and T. Shiota
Determinants of Recurrent or Residual Functional Tricuspid Regurgitation After Tricuspid Annuloplasty
Circulation,
July 4, 2006;
114(1_suppl):
I-582 - I-587.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Thistlethwaite, A. Kemp, L. Du, M. M. Madani, and S. W. Jamieson
Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension
J. Thorac. Cardiovasc. Surg.,
February 1, 2006;
131(2):
307 - 313.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. H. Rahimtoola
The Year in Valvular Heart Disease
J. Am. Coll. Cardiol.,
January 17, 2006;
47(2):
427 - 439.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Matsunaga and C. M. G. Duran
Progression of Tricuspid Regurgitation After Repaired Functional Ischemic Mitral Regurgitation
Circulation,
August 30, 2005;
112(9_suppl):
I-453 - I-457.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
